Charlotte Proudman hails 'turning point' for women's rights and a barrister's freedom of speech | 1yr
Charlotte Proudman hails 'turning point' for women's rights and a barrister's freedom of speech | 1yr
BCLP report shows corruption remains a significant challenge for the arbitration process | 1yr
Leading litigators James Keyte and Enoch Liang join the disputes powerhouse | 1yr
Daniel Hunt joins as a partner, adding collective actions and mainstream antitrust expertise | 1yr
Former Clyde & Co partner Sapna Jhangiani KC joins London commercial set in Singapore | 1yr
Rebekah Finch of TLT examines how the recent phone-hacking litigation highlights the power of the SIOC to offer victims vindication and restore reputations | 1yr
Agreement set to be challenged by litigation funder is subject to approval by Competition Appeal Tribunal | 1yr
Ministerial reshuffle prompted by resignation of Louise Haigh as transport secretary | 1yr
Three made up in London following exit of office managing partner Justin Stock for Akin in the summer | 1yr
Firm could cut up to 100 roles, according to reports | 1yr
Nearly 70% agree that an increase in group claims would lead to improvements in corporate behaviour, according to research by Portland Communications | 1yr
Opt out claim alleges 65 million consumers were impacted by anti-competitive practices in mobile search | 1yr
Luke Tucker Harrison’s prognosis is good, following successful treatment | 1yr
Promotions concentrated in firm’s Chicago headquarters, London and New York | 1yr
Litigators Elizabeth Stotland Weiswasser and Anish Desai head to Paul Weiss, while restructuring partner Ray Schrock joins Latham | 1yr
Paul Tan joins the set to expand its footprint in Singapore and the wider Asia region | 1yr
Claim filed with the Competition Appeal Tribunal alleges Apple's cloud storage service breached UK competition law | 1yr
New venture with Hunt ADR will use technology and a fixed-fee structure to streamline the disputes process | 1yr
Deal, subject to partner approval, will create firm with $2bn-plus revenue | 1yr
Laurence Lieberman led his former firm’s life sciences commercial disputes group | 1yr